Amsterdam, Netherlands

Victor Willem Van Beusechem

This inventor holds 5 USPTO granted patents and 2 EPO patents. Top assignees: Introgene B.v., Vereniging Voor Christelijik Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg, Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg. Active years: 1997-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victor Willem Van Beusechem. Retrieved from https://idiyas.com/inventor/victor-willem-van-beusechem

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 80.0


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 1997-2012

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Victor Willem Van Beusechem: Innovator in Viral Therapeutics

Introduction

Victor Willem Van Beusechem is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of viral therapeutics, holding a total of five patents. His work focuses on the development of replication-competent viruses that can effectively target and silence specific gene expressions in cells.

Latest Patents

One of his latest patents involves replication-competent viruses capable of silencing virus inhibitory factor expression. This invention describes a virus that can replicate and has lytic capacity in target cells. The virus includes a DNA sequence coding for a silencing factor that reduces the expression of a target gene in those cells. This technology has potential applications in the preparation of medicaments and methods for lysing target cells that express a virus inhibitory factor.

Another significant patent by Van Beusechem is related to viruses with enhanced lytic potency. This invention describes a recombinant virus capable of replication and lytic activity in target cells that are hampered in the p53-dependent apoptosis pathway. The virus includes a coding sequence for a restoring factor that can restore the p53 apoptosis pathway in target cells. This innovation is particularly relevant for developing medicaments aimed at suppressing uncontrolled cell growth.

Career Highlights

Throughout his career, Van Beusechem has worked with several prominent organizations. He has been associated with Introgene B.V., a company focused on gene therapy, and the Association for Christian Higher Education, Scientific Research, and Patient Care, which emphasizes the integration of faith and science in research.

Collaborations

Some of his notable coworkers include Domenico Valerio and Willem-Ronald Gerritsen, who have collaborated with him on various projects in the field of viral therapeutics.

Conclusion

Victor Willem Van Beusechem's innovative work in the development of viral therapeutics has the potential to significantly impact medical treatments. His patents reflect a deep understanding of viral mechanisms and their applications in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…